(Q64041021)
Statements
Dose Finding and Randomized, Multicenter, Placebo-Controlled, Phase 2 Study of Enzastaurin and Sunitinib Versus Placebo and Sunitinib in Patients With Metastatic Renal Cell Carcinoma (English)
0 references
30 June 2008
0 references
15 February 2010
0 references
26
0 references
18 year
0 references